Research
Biosynthesis and characterization of arsenic trioxide (As2O3) nanoparticles and evaluation of their antibacterial activity against multidrug-resistant Escherichia coli
Nature ·
The Brief
- The study reports the biosynthesis of arsenic trioxide (As2O3) nanoparticles.
- The authors characterize the nanoparticles and evaluate their antibacterial activity.
- The tested target is multidrug-resistant Escherichia coli.
Why it matters
It explores a nanoparticle-based approach against multidrug-resistant bacteria, a growing concern for antibiotic research. The source provides only the title, so the strength of the evidence cannot be assessed here.
Who’s affected
- researchers in nanomedicine and antimicrobial resistance
- #nanoparticles
- #antibacterial
- #antimicrobial resistance
- #escherichia coli
- #arsenic trioxide